- Home
- CSAN vs VCEL Comparison
CSAN vs VCEL Comparison
Compare CSAN & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSAN
- VCEL
- Stock Information
- Founded
- CSAN 1936
- VCEL 1989
- Country
- CSAN Brazil
- VCEL United States
- Employees
- CSAN N/A
- VCEL N/A
- Industry
- CSAN Retail-Auto Dealers and Gas Stations
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CSAN Consumer Discretionary
- VCEL Health Care
- Exchange
- CSAN Nasdaq
- VCEL Nasdaq
- Market Cap
- CSAN 2.0B
- VCEL 2.1B
- IPO Year
- CSAN N/A
- VCEL 1997
- Fundamental
- Price
- CSAN $4.08
- VCEL $35.76
- Analyst Decision
- CSAN Strong Buy
- VCEL Strong Buy
- Analyst Count
- CSAN 1
- VCEL 7
- Target Price
- CSAN $19.00
- VCEL $61.29
- AVG Volume (30 Days)
- CSAN 1.3M
- VCEL 592.1K
- Earning Date
- CSAN 08-14-2025
- VCEL 07-31-2025
- Dividend Yield
- CSAN 7.96%
- VCEL N/A
- EPS Growth
- CSAN N/A
- VCEL 2045.40
- EPS
- CSAN N/A
- VCEL 0.13
- Revenue
- CSAN $7,993,490,490.00
- VCEL $249,119,000.00
- Revenue This Year
- CSAN $262.72
- VCEL $18.35
- Revenue Next Year
- CSAN $2.62
- VCEL $22.47
- P/E Ratio
- CSAN N/A
- VCEL $275.10
- Revenue Growth
- CSAN 7.98
- VCEL 16.13
- 52 Week Low
- CSAN $3.80
- VCEL $33.09
- 52 Week High
- CSAN $10.28
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- CSAN 41.33
- VCEL 47.67
- Support Level
- CSAN $3.93
- VCEL $35.53
- Resistance Level
- CSAN $4.12
- VCEL $37.36
- Average True Range (ATR)
- CSAN 0.15
- VCEL 1.37
- MACD
- CSAN 0.01
- VCEL 0.16
- Stochastic Oscillator
- CSAN 26.90
- VCEL 56.37
About CSAN Cosan S.A. ADS
Cosan SA engages in several services throughout the energy and logistics sectors. Its reportable segments are Raizen, Compass, Moove, Rumo, and Radar. It generates the majority of its revenue from Raizen which operates in the production, commercialization, origination, and trading of ethanol, bioenergy, resale, and trading of electricity, renewable sources, marketing, origination, and trading of sugar and fuels, and lubricant.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.